Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Symposium    crawled date : 2022 - 10 - 26    save search

ESSA Pharma Presents Preclinical Data for its First Generation Androgen Receptor N-Terminal Domain Degrader at the 34th EORTC-NCI-AACR Symposium
Published: 2022-10-26 (Crawled : 22:00) - biospace.com/
EPIX | $6.67 -5.66% -6.0% 36K twitter stocktwits trandingview |
Health Technology
| | O: 19.19% H: 148.78% C: 135.12%

pharma preclinical symposium
Rain Therapeutics Announces a Poster Presentation at the 34th EORTC/AACR/NCI Symposium
Published: 2022-10-26 (Crawled : 19:00) - globenewswire.com
RAIN | $1.21 0.0% 3.7M twitter stocktwits trandingview |
Manufacturing
| | O: 5.5% H: 5.04% C: -2.52%

symposium therapeutics presentation
Theseus Pharmaceuticals Presents Preclinical Data Characterizing THE-349, its Fourth-Generation EGFR Inhibitor in Development for NSCLC, at the 34th EORTC-NCI-AACR Symposium
Published: 2022-10-26 (Crawled : 14:20) - biospace.com/
THRX | $4.06 0.49% 0 twitter stocktwits trandingview |
| | O: 1.78% H: 6.64% C: 0.87%

the-349 pharmaceuticals preclinical symposium
Exscientia Presents Novel Patient Stratification and Biomarker Data for GTAEXS-617 at the 34th EORTC-NCI-AACR Annual Symposium
Published: 2022-10-26 (Crawled : 13:00) - biospace.com/
EXAI | $4.35 0.69% 0.69% 330K twitter stocktwits trandingview |
| | O: 0.0% H: 6.78% C: 1.4%

taexs-617 symposium biomarker
Black Diamond Therapeutics Presents Preclinical Data on BDTX-1535 and BDTX-4933 at the 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Published: 2022-10-26 (Crawled : 12:20) - globenewswire.com
BDTX A | $5.295 -7.11% -7.65% 1.9M twitter stocktwits trandingview |
Health Technology
| | O: 0.6% H: 11.98% C: 4.19%

bdtx-1535 preclinical symposium therapeutics molecular cancer
Merus Presents First in Human Data on MCLA-129 at the 34th EORTC/NCI/AACR (ENA) Symposium on Molecular Targets and Cancer Therapeutics
Published: 2022-10-26 (Crawled : 09:00) - globenewswire.com
MRUS | $40.41 -1.56% -1.58% 240K twitter stocktwits trandingview |
Health Technology
| | O: -1.06% H: 3.59% C: -8.84%

mcla-129 symposium therapeutics molecular cancer
Gainers vs Losers
64% 36%

Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M twitter stocktwits trandingview |
Finance

ZCMD | $2.86 108.76% 52.1% 2.3M twitter stocktwits trandingview |
Commercial Services

INVO | $1.555 104.6% 51.13% 5M twitter stocktwits trandingview |
Health Technology

ISPC | $0.437 105.16% 49.53% 37M twitter stocktwits trandingview |
Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M twitter stocktwits trandingview |

OST | $0.499 21.38% 45.26% 1.9M twitter stocktwits trandingview |

XPON | News | $3.1 60.62% 37.74% 17M twitter stocktwits trandingview |

TIRX | $0.7 44.39% 30.74% 58M twitter stocktwits trandingview |

BNTC | News | $6.92 44.17% 30.64% 3.5M twitter stocktwits trandingview |
Health Technology

GGE | $0.035 19.86% 29.3% 64M twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.